Call for Proposals for R&D Demonstration Projects
In accordance with the World Health Assembly Resolution 66.22 titled as “Follow up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination”
The resolution (WHA66.22) requests the Director General of the WHO to facilitate through regional consultations and broad engagement of relevant stakeholders the implementation of a few health research and development (R&D) demonstration projects to address identified gaps that disproportionately affect developing countries, particularly the poor, and for which immediate action can be taken;
The selection of the projects will be based primarily upon two considerations. First, the Demonstration Projects should involve development of health technologies (medicines; diagnostics; medical devices; vaccines etc.) for diseases that disproportionately affect developing countries, for which R&D gaps have been identified but these gaps are not being addressed due to market failures. Second, the projects must demonstrate innovative and sustainable financing and coordination approaches to address identified R&D gaps.
Objectives of the Call
This call is being launched to solicit proposals for R&D demonstration projects that:
- address identified R&D gaps related to discovery, development and/or delivery, including promising product pipelines, for diseases that disproportionally affect developing countries, particularly the poor, and for which immediate action can be taken;
- utilize collaborative approaches, including open-knowledge approaches, for R&D coordination;
- promote the de-linkage of the cost of R&D from product price; and
- propose innovative and sustainable financing mechanisms including pooled funding;
The Call is Open to
The call is open to Member States and their relevant public and private institutions, regional and global initiatives including relevant networks, consortia, public-private partnerships as well as product development partnerships. The applying institutions and individuals must have deep knowledge, expertise and track record in R&D for health technologies for diseases that disproportionately affect developing countries. Applications that are transformative in nature, i.e. address a critical R&D gap in holistic and innovative manner with appropriate regional or global coordination approach, will be given priority.
How to Submit Proposals?
All proposals must be submitted on a standard template.
The submissions should be sent by email (CEWGDemoProjects@wpro.who.int) to WHO Regional Office for Western Pacific by 5 PM, local Manila Time, Friday, November 1, 2013.
For any clarification or queries about this call, please send an email to Dr. Manju Rani, at CEWGDemoProjects@wpro.who.int
Review Process and next steps
The submitted proposals will be assessed by a regional-level Expert Group set up specifically to review the submitted proposals in accordance with the objectives of this call and up to four proposals will be short listed. Representatives of Member States and a range of other relevant regional stakeholders are expected to participate in Expert Group.
The short listed proposals will be transmitted to WHO headquarters and further assessed during a global technical consultative meeting of experts and Member States planned for 3-5 December 2013 at WHO headquarters in Geneva at which few most befitting projects would be selected.
A report will be prepared about the selected projects for discussion during the 134th WHO Executive Board (EB) meeting on 20-25 January 2014 and the report will be modified in the light of the EB discussion and advice.
This report will then be presented to the 67th World Health Assembly in May 2014, for discussion and possible endorsement.
Once endorsed by the WHA, the WHO secretariat will start convening meetings of possible partners for each of the selected projects and mobilize resources from various sources for their implementation.